ATRI - Atrion Corp Analyst Forecast Prices

Corporate company logo of Atrion Corp. (ATRI)

Atrion Corporation (ATRI) business relies on stable demand in cardiac surgery and ophthalmology, making it crisis-resistant. This price chart reflects the current consensus at 298.77. Atrion Corporation (ATRI) integrates its components into partners' OEM projects, creating high switching costs. Meanwhile, the modernization of casting lines and packaging at its plants allows for maximum optimization of component output.

ATRI: Atrion Analyst Consensus Forecast 07/04/2022 - 08/31/2024

Analytical breakdowns for Atrion Corp (ATRI)

- stock value and consensus price forecast:
Stock Price atrioncorp.com|ATRI - Consensus Target
- market capitalization statistics:
Market Value Atrion Corp|ATRI - Total Company Value
- book capitalization information:
Accounting Value of a Share Atrion|ATRI - Book Capitalization|Market Capitalization to Book Value atrioncorp.com|ATRI - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Atrion Corporation|ATRI - Long-Term Debt to Capital|Current Liabilities to Capital Atrion Corporation Inc.|ATRI - Company Aggregate Debts|Debt to Book Value Ratio Atrion Corp|ATRI - Company Long-Term Debts|Short-Term Debt Volume Atrion|Quick Liquidity Indicator atrioncorp.com
- earnings and valuation multiples information:
ATRI - Net Profit|Projected Future Earnings Atrion Corporation|ATRI - Price to Earnings Ratio|Future Price to Earnings Atrion Corp.|ATRI - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Atrion Corp|ATRI - Operating profit EBITDA|Net earnings per share for the last four quarters Atrion|ATRI - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months atrioncorp.com|ATRI - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Atrion Corporation
General company analysis:atrioncorp.com (ATRI)
Original product of Atrion

This indicator aggregates the average target prices for Atrion Corporation (ATRI) shares from leading analysts, promptly reflecting revisions to business development models between quarterly reports. The trend of this market target for the stock demonstrates how confidently Atrion Corporation management is handling raw material logistics and demand for anesthesiology components while maintaining a stable operating margin.

Competing companies

Analyst Consensus Forecast intuitive.com (ISRG)|Danaher - Consensus Target|Analyst Forecast Prices BDX (BD)|STE - Price Target Chart|Fair Value Consensus WST (West Pharma Corp)|BAX: Analyst Consensus Forecast|MASI - Analyst Median Target|Price Target Chart Stevanato Group|Consensus Target Teleflex Inc. (TFX)|Analyst Consensus Forecast MMSI|NVST - Average Forecast Price|Analyst Consensus Forecast ICUI (ICU Medical, Inc.)|XRAY: Broker Consensus Forecast|LeMaitre Vascular - Analyst Consensus Forecast|Analyst Median Target AtriCure Inc ATRC|STAA: Analyst Consensus Forecast|Consensus Target ChromaDex Corp.|ZIMV (ZimVie Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast angiodynamics.com|Price Target Chart Cerus (CERS)|Price Target Chart TKNO (Alpha Teknova)|Monogram Technologies Inc - Consensus Target|Fair Value Consensus STSS|InfuSystem Inc - Analyst Consensus Forecast|Analyst Median Target utahmed.com UTMD|korumedical.com (KRMD) - Price Target Chart|Broker Consensus Forecast NYXH|Price Target Chart Microbot Medical Inc|Pro-Dex Inc. (PDEX) - Analyst Median Target|Consensus Target ZTEK (Zentek Ltd.)|Analyst Forecast Prices ELUT|Price Target Chart Milestone Scientific Inc. MLSS|Fair Value Consensus NXGL|RVP: Consensus Target|HBIO - Analyst Consensus Forecast|Femasys Inc. (FEMY) - Price Target Chart|Consensus Target Meihua Medical Technologies Co., Ltd.|POAI (Predictive Oncology Inc) - Analyst Consensus Forecast|Average Forecast Price Callan JMB Corp CJMB|Price Target Chart NeuroMetrix Corp (NURO)